摘要
PET/MRI作为新出现的融合影像技术,其临床应用价值尚未得到充分证实。与CT相比,MRI具有软组织对比分辨力高、无辐射、多参数成像、能够提供更多功能信息的优势,PET与MRI的融合对于肺癌的潜在应用价值可能要优于PET/CT。简述不同的PET/MRI系统的设计,并从肺结节的检出、鉴别诊断、TNM分期、预后/早期疗效评价/肿瘤复发4个方面介绍PET/MRI在肺癌中的潜在临床价值。
Positron emission tomography/magnetic resonance imaging（PET/MRI）,as a new hybrid imaging tool,has not been fully studied.Considering the priority of MRI to CT,such as high soft tissue contrast,no ionizing radiation,multiparameters imaging,and capability of providing more function information,the combination of PET and MRI may have greater potential in lung cancer than PET/CT.In this review article,the different PET/MRI systems are introduced briefly.The potential application of PET/MRI in lung cancer are mainly described in terms of detection of lung nodule,differential diagnosis of lung nodule,TNM staging,prognostic prediction,therapeutic response evaluation,and recurrence detection.
出处
《国际医学放射学杂志》
2016年第3期285-290,共6页
International Journal of Medical Radiology
基金
国家自然基金重点项目(81230030)
国家自然基金面上项目(81370035)
国家自然基金青年项目(81000602)
上海市生物医药处重大专项(13411950100)
上海市浦江人才计划(15PJD002)
